Clinical Trials

Autism Spectrum Disorder, Trisomy 13 Syndrome, Cri-du-Chat Syndrome, De Lange Syndrome, Down Syndrome, Fragile X Syndrome, Intellectual Disability, Motor Activity, Prader-Willi Syndrome, Rubinstein-Taybi Syndrome, WAGR Syndrome, Williams Syndrome, X-Linked Intellectual Disability, Neurodevelopmental Disorders

Creatine deficiency, X-linked, Telomeric 22q13 Monosomy Syndrome, Chromosome 15q, partial deletion, Fragile X Syndrome, Hamartoma Syndrome, Multiple, Tuberous Sclerosis, Rett Syndrome, Angelman Syndrome

Hydrocephalus, X-linked, Neurofibromatosis-Noonan syndrome, Anemia, Sickle Cell, Hemophilia B, Cystic Fibrosis, Fragile X Syndrome, Hemophilia A, Huntington Disease, Myotonic Dystrophy, Polycystic Kidney, Autosomal Recessive, Neurofibromatoses, Muscular Dystrophy, Duchenne

Telomeric 22q13 Monosomy Syndrome, Developmental Disabilities, DiGeorge Syndrome, Down Syndrome, Fragile X Syndrome, Klinefelter Syndrome, Prader-Willi Syndrome, Tuberous Sclerosis, Turner Syndrome, Rett Syndrome, Angelman Syndrome, Williams Syndrome, Muscular Dystrophy, Duchenne, Smith-Magenis Syndrome

Autism Spectrum Disorder, Anxiety Disorders, Attention Deficit Disorder with Hyperactivity, Autistic Disorder, DiGeorge Syndrome, Fragile X Syndrome, Tourette Syndrome, Tic Disorders, Tuberous Sclerosis, 22q11 Deletion Syndrome, Neurodevelopmental Disorders

Severe combined immunodeficiency due to adenosine deaminase deficiency, 3-methylcrotonyl CoA carboxylase 1 deficiency, 3-methylcrotonyl CoA carboxylase 2 deficiency, 3-Hydroxyacyl-CoA Dehydrogenase Deficiency, Ataxia with vitamin E deficiency, Beta ketothiolase deficiency, Bile acid synthesis defect, congenital, 2, Carnitine palmitoyl transferase 1A deficiency, Carnitine palmitoyl transferase 2 deficiency, Creatine deficiency, X-linked, Adrenocorticotropic hormone deficiency, Maple syrup urine disease, type 1A, Maple syrup urine disease, type 1B, Maple syrup urine disease, type 2, Congenital disorder of glycosylation type 1B, Medium chain acyl CoA dehydrogenase deficiency, N-acetyl glutamate synthetase deficiency, Niemann-Pick disease, type C2, Pyridoxine-dependent epilepsy, VLCAD deficiency, Primary hyperoxaluria type 1, Primary hyperoxaluria type 2, Waardenburg syndrome type 2, Waardenburg syndrome type 2A, Usher syndrome, type 1B, Usher syndrome, type 1C, Usher syndrome, type 1F, Amaurosis congenita of Leber, type 2, Glut1 Deficiency Syndrome, Glutaric Acidemia I, Glutathione synthetase deficiency, Brown-Vialetto-Van Laere syndrome, Methylenetetrahydrofolate reductase deficiency, Methylmalonic acidemia with homocystinuria, Methylmalonic aciduria cblA type, Methylmalonic aciduria cblB type, Pitt-Hopkins syndrome, Stickler syndrome, type 1, Stickler syndrome, type 2, Segawa syndrome, autosomal recessive, Guanidinoacetate methyltransferase deficiency, Basal ganglia disease, biotin-responsive, Acidemia, isovaleric, Acrodermatitis enteropathica, Adenine phosphoribosyltransferase deficiency, Adrenal hyperplasia, congenital, type 5, 3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency, Hyperinsulinemic hypoglycemia, familial, 6, HHH syndrome, Glycogen Storage Disease IB, Hyperphenylalaninemia, BH4-Deficient, B, Thyroid Dyshormonogenesis 3, Thyroid Dyshormonogenesis 5, Glycogen Storage Disease IC, Carnitine-Acylcarnitine Translocase Deficiency, Glycogen Storage Disease IXB, Thyroid Dyshormonogenesis 2A, Intrinsic Factor Deficiency, Hyperparathyroidism, Neonatal Severe Primary, Diabetes Mellitus, Permanent Neonatal, With Neurologic Features, Diabetes Mellitus, Permanent Neonatal, Maturity-Onset Diabetes of the Young, Type 4, Thyroid Dyshormonogenesis 6, Thyroid Dyshormonogenesis 1, Tuberous Sclerosis 1, Molybdenum Cofactor Deficiency, Complementation Group A, Methylmalonic Aciduria due to Methylmalonyl-CoA Mutase Deficiency, Homocystinuria-Megaloblastic Anemia due to Defect in Cobalamin Metabolism, CblE Complementation Type, Tuberous Sclerosis 2, Pyridoxamine 5-Prime-Phosphate Oxidase Deficiency, Trifunctional Protein Deficiency With Myopathy And Neuropathy, Arginine-Glycine Amidinotransferase Deficiency, Jervell And Lange-Nielsen Syndrome 2, Glycogen Storage Disease, Type IXA2, Pituitary Hormone Deficiency, Combined, 1, Glycogen Storage Disease IXC, Anemia, Sickle Cell, Hemophilia B, Congenital Hypothyroidism, Cystic Fibrosis, Cystinosis, Diabetes Mellitus, Disease, Epilepsy, Epilepsies, Myoclonic, Factor VII Deficiency, Factor X Deficiency, Fragile X Syndrome, Fructose Intolerance, Galactosemias, Glycogen Storage Disease Type I, Glucosephosphate Dehydrogenase Deficiency, Glycogen Storage Disease Type II, Granulomatous Disease, Chronic, Hemophilia A, Hepatolenticular Degeneration, Homocystinuria, Hypophosphatasia, Menkes Kinky Hair Syndrome, Leukodystrophy, Globoid Cell, Leukodystrophy, Metachromatic, Mucopolysaccharidosis I, Mucopolysaccharidosis III, Mucopolysaccharidosis IV, Mucopolysaccharidosis VI, Muscular Atrophy, Spinal, Nephritis, Hereditary, Phenylketonurias, Prader-Willi Syndrome, Pseudohypoaldosteronism, Retinoblastoma, Stress Disorders, Post-Traumatic, Waardenburg Syndrome, Wolman Disease, Fructose-1,6-Diphosphatase Deficiency, Rett Syndrome, Gyrate Atrophy, Mucopolysaccharidosis II, Mucopolysaccharidosis VII, beta-Thalassemia, Angelman Syndrome, Canavan Disease, Multiple Endocrine Neoplasia Type 2b, Peroxisomal Disorders, Smith-Lemli-Opitz Syndrome, Xanthomatosis, Cerebrotendinous, Citrullinemia, Hyperargininemia, Ornithine Carbamoyltransferase Deficiency Disease, Carbamoyl-Phosphate Synthase I Deficiency Disease, Tyrosinemias, Muscular Dystrophy, Duchenne, Aortic Stenosis, Supravalvular, Hermanski-Pudlak Syndrome, Biotinidase Deficiency, Holocarboxylase Synthetase Deficiency, Jervell-Lange Nielsen Syndrome, Mineralocorticoid Excess Syndrome, Apparent, Congenital Hyperinsulinism, Niemann-Pick Disease, Type A, Niemann-Pick Disease, Type C, Familial Hypophosphatemic Rickets, X-Linked Combined Immunodeficiency Diseases, Propionic Acidemia, von Willebrand Disease, Type 3, Argininosuccinic Aciduria, Barth Syndrome, Liddle Syndrome